Main trends of immune effects triggered by nanomedicines in preclinical studies

Blanka Halamoda-Kenzaoui, Susanne Bremer-Hoffmann Directorate F-Health, Consumers and Reference Materials, European Commission Joint Research Centre (JRC), Ispra (VA), Italy Abstract: The application of nanotechnology to emerging medicinal products is a crucial parameter for the implementation of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Halamoda-Kenzaoui B, Bremer-Hoffmann S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/0b56e46c056e4b8399a74ddb452bae6a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares